Text Size

Intravascular Ultrasound for Hepatocellular Carcinoma Staging

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2007 by University Hospital, Geneva.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
University Hospital, Geneva
ClinicalTrials.gov Identifier:
NCT00474734
First received: May 15, 2007
Last updated: May 16, 2007
Last verified: May 2007
History of Changes
  Purpose

To diagnose hepatocellular carcinoma (HCC) and to determine the extent of the disease, a triphasic CT scan or a magnetic resonance imaging are required. The characterization of hepatic nodules is more difficult when the HCC lesions have a diameter of less than 2 cm.

Since accuracy in the assessment of the number and the size of HCC nodules, as well as of the invasion of blood vessels is crucial to determine outcome after liver transplantation due to tumour recurrence, there is a need for techniques with a higher definition potential.

As a consequence, to improve outcome and to optimize organ allocation, patients on the liver transplantation waiting list might benefit from intravascular ultrasound as an additional examination to complete the pre-transplant tumour staging process.


Condition Intervention
Hepatocellular Carcinoma
 Device: Intravascular ultrasound of the liver

Study Type: Observational
Study Design: Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Longitudinal
Time Perspective: Prospective
Official Title: Intravascular Ultrasound for the Staging of Hepatocellular Carcinoma: a Pilot Study

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by University Hospital, Geneva:

Study Start Date: May 2007
Estimated Study Completion Date: September 2007
  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • hepatocellular carcinoma nodules
  • patient on liver transplantation waiting list
  • written informed consent

Exclusion Criteria:

  • thrombosis of hepatic veins or vena cava
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00474734

Contacts
Contact: Antoine Hadengue, Prof. +41 22 37 29 340 antoine.hadengue@hcuge.ch

Locations
Switzerland
University Hospital Geneva Recruiting
Geneva, Switzerland
Contact: Andrea De Gottardi, MD PhD     +41 22 37 29 256     andrea.degottardi@hcuge.ch    
Sponsors and Collaborators
University Hospital, Geneva
Investigators
Study Chair: Antoine Hadengue, Prof. University Hospital, Geneva
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00474734     History of Changes
Obsolete Identifiers: NCT00472979
Other Study ID Numbers: 07-063
Study First Received: May 15, 2007
Last Updated: May 16, 2007
Health Authority: Switzerland: Swissmedic

Keywords provided by University Hospital, Geneva:
hepatocellular carcinoma
liver transplantation
staging
intravascular ultrasound

Additional relevant MeSH terms:
Carcinoma
Carcinoma, Hepatocellular
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Neoplasms
Adenocarcinoma
 Liver Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Digestive System Diseases
Liver Diseases

ClinicalTrials.gov processed this record on May 19, 2013